Podcasts about preventive cardiology

Heart disease is not only a man's disease. It is the number one killer of women, responsible for ten times more deaths than breast cancer. And yet most women have never had a real conversation about their cardiovascular risk, because the medical system was not built to catch it in them.Dr. Martha Gulati is the Director of Preventive Cardiology and Associate Director of the Barbra Streisand Women's Heart Center at Cedars-Sinai, Director of the Davis Women's Heart Center at Houston Methodist, and author of Saving Women's Hearts. Her own quote has become one of the most cited lines in women's cardiology: "Heart disease is the number one killer of women, but lack of awareness is a close second."This conversation goes into how the female heart develops disease differently, why women's symptoms get dismissed even when they use the words chest pain, and the pregnancy complications, hormonal history, and inflammatory conditions that quietly raise cardiovascular risk for decades before anything shows up on a standard panel.Join the most comprehensive *female-specific community for health and longevity optimization.* After over a decade dedicated to human performance and women's health, I created this space to share everything you need to know to optimize health and lifespan. Inside, you'll get access to exclusive protocols, live Q&As, the latest female longevity science, and a private, supportive community of like-minded women.⁠https://kayla-barnes-lentz.circle.so/female-longevity-community⁠If you're already paying attention to food, sleep, and overall health, cleaning products are another place where exposure adds up quickly. Branch Basics is a simple way to clean your home with fewer unnecessary ingredients and less clutter under the sink.⁠https://branchbasics.com/KAYLA15⁠ What we cover:How women's heart attack symptoms differ from men and why they still get dismissed in the ERWhy women wait longer, receive fewer tests, and are less likely to see a cardiologist when they arrive with chest painThe labs every woman should ask for, including LP(a), high-sensitivity CRP, and ApoB, with specific reference rangesWhy women get more cardiovascular benefit per minute of exercise than men, and what the exercise prescription actually looks likeMediterranean diet, hidden salt, sleep, and the lifestyle foundations that move the needleConnect with Kayla:Instagram: https://www.instagram.com/kaylabarnes/TikTok: https://www.tiktok.com/@femalelongevityTwitter:https://x.com/femalelongevityWebsite:https://www.kaylabarnes.com/Spotify:https://open.spotify.com/show/4OLWWn22RGB0argbRPvAaQ?si=8e91b3c9e0ce4054Apple:https://podcasts.apple.com/us/podcast/longevity-optimization-with-kayla-barnes-lentz/id1591130227Follow Her Female Protocol: https://www.protocol.kaylabarnes.comConnect with Dr. Marth Gulati:Website: https://www.drmarthagulati.com/Instagram: https://www.instagram.com/drmarthagulatiLinkedIn: https://www.linkedin.com/in/martha-gulati-9b410496/Her Book (Saving Women's Hearts): https://www.drmarthagulati.com/general-2 #WomensHealth #HeartDisease #WomensHeartHealth #Cardiology #FemaleLongevity #HeartHealth #LongevityPodcast #PreventiveCardiology #HeartDiseaseInWomen #WomensCardiology #LongevityOptimization #KaylaBarnesLentz #HeartHealthForWomen #FemaleHealth #MarthаGulati

Adam talks with American journalist Patrick Radden Keefe about his book London Falling: A Mysterious Death in a Gilded City and a Family's Search for Truth, the challenges presented by parenting adolescents, the seductive power of movies like The Wolf Of Wall Street and Patrick's own efforts to resist the glamorising effect of TV and film during production of the TV adaptation of his book about the Troubles in Northern Ireland, Say Nothing, and Adam's own ludicrous taste of the criminal life in his early adolescence. There's also chat about why David Byrne's live show was the best live music show Adam has ever seen and whether it's OK to stand up at a seated music show.Conversation recorded face-to-face in Bath on 7 May, 2026LONDON FALLING by Patrick Radden Keefe - 2026 (Waterstones)CLARIFICATION RE. STATINS vs GLP-1sResponding to Adam's comments about statins at the end of the conversation with Patrick, this was sent in by Dr Mit Shah, MBBS BSc (Hons) PhD, Consultant Cardiologist in Preventive Cardiology, Harefield Hospital:I'm a consultant cardiologist specialising in lipid disorders and preventive cardiology. While both GLP-1 drugs and statins can reduce cardiovascular risk, they work through very different mechanisms and treat different underlying problems. Statins are specifically used to lower LDL cholesterol, whereas GLP-1 drugs mainly work through the blood glucose and weight-loss pathway, with only modest effects on cholesterol.Statins have become somewhat unfairly maligned through widespread misinformation and exaggerated claims about side effects, despite very strong clinical evidence for benefit. In fact, researchers have even performed randomised trials demonstrating a significant “nocebo effect”, where patients experience expected side effects even when taking placebo tablets due to their preconceived expectations and worries. Daily, I see patients with severe (sometimes genetic) cholesterol disorders who have a critical need for statin therapy, but who are understandably hesitant because of what they've heard online. I worry that the idea that GLP-1s could simply replace statins may unintentionally add to that confusion.SUBMIT QUESTIONS FOR Q&A EPISODE: Adambuxtonpodcast@gmail.comThanks to Diggory Waite and Claire Broughton at Hattrick and Séamus Murphy Mitchell for production support.Podcast illustration by Helen GreenSPONSOR: SAILY

Lp(a) affects 25% of people, increases heart attack and stroke risk, and is rarely tested—Dr. Kahn urges early detection. #Lp(a) #CardiacRisk #EarlyScreening #SilentKiller

Statin use in the elderly, push for PCSK9 drugs, and pressures on clinicians show how economic interests shape patient care. #StatinsAndSeniors #PCSK9 #DrugMarketing #HealthTalks

Philip Clark is joined by Dr Stephen Fenton, has developed The 5 CH Lifestyle, also the title of his new book, to discuss how early detection combined with simple diet and lifestyle changes can help heart health.

With Liemena Harold Adrian, Syarifah Ambami Rato Ebu General Academic Hospital, Surabaya - Indonesia and Shelley Zieroth, St. Boniface Hospital, University of Manitoba, Winnipeg - Canada. In this episode,Liemena Harold Adrian and Shelley Zieroth discuss heart failure in post–myocardial infarction patients, covering how myocardial infarction leads to the development of heart failure despite advances in reperfusion and acute care. The conversation addresses the epidemiology and underlying pathophysiology, approaches to early prevention and screening, diagnostic tools, as well as key interventions in the acute and early post-MI phases that may alter heart failure trajectories. They outline management with guideline-directed medical therapy, review current studies on heart failure–modifying therapies (such as the DAPA-MI and EMPACT-MI trials), and address indications for advanced therapies in post-MI populations. The episode also highlights the importance of early diagnosis, prompt recognition, and key evidence gaps in the field. Recommended readings: Akhtar KH, Khan MS, Baron SJ, et al. The Spectrum of Post-Myocardial Infarction Care: From Acute Ischemia to Heart Failurehttps://doi.org/10.1016/j.pcad.2024.01.017. Prog Cardiovasc Dis. (2024); 82: 15-25. DOI: 10.1016/j.pcad.2024.01.017. Butler J, Hammonds K, Talha KM, et al. Incident Heart Failure and Recurrent Coronary Events Following Acute Myocardial Infarctionhttps://doi.org/10.1093/eurheartj/ehae885. Eur Heart J (2025); 46: 1540-50. DOI: 10.1093/eurheartj/ehae885. Butler J, Jones WS, Udell JA. Empagliflozin after Acute Myocardial Infarction. N Engl J Med (2024); 390: 1455-66. DOI: 10.1056/NEJMoa2314051. Fioretti F, Butler J, Udell JA, et al. Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI. ESC Heart Failure (2025); 12: 3940-3952. DOI: 10.1002/ehf2.15393. Hernandez AF, Udell JA, Jones WS. Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial. Circulation (2024); 149: 1627–1638. DOI: 10.1161/CIRCULATIONAHA.124.069217. Jenca D, Melenovsky V, Stehlik J, et al. Heart Failure after Myocardial Infarction: Incidence and Predictors. ESC Heart Failure (2021): 8: 222-237. DOI: 10.1002/ehf2.13144. Lala A, Beavers C, Blumer V, et al. The Continuum of Prevention and Heart Failure in Cardiovascular Medicine: A Joint Scientific Statement from the Heart Failure Society of America and The American Society for Preventive Cardiology. Journal of Cardiac Failure (2026); 32: 75-105. Petrie MC, Udell JA, Anker SD, et al. Empagliflozin in Acute Myocardial Infarction in Patients with and without Type 2 Diabetes: A Pre-specified Analysis of the EMPACT-MI Trial. Eur J of Heart Fail. (2025): 27: 577-588. DOI: 10.1002/ejhf.3548. Zieroth S, Rizi SS. Time Is of the Essence. JACC: Heart Failure (2023): 11(6): 713-714. DOI: 10.1016/j.jchf.2023.03.022 This 2026 HFA Cardio Talk podcast series is supported by Bayer in the form of unrestricted financial support. The discussion has not been influenced in any way by its sponsor.

In this sponsored episode from Novartis Pharmaceuticals Corporation, a leading preventive cardiologist walks through the 2026 cholesterol guideline update and what it means in practice. Seth J. Baum, a Columbia-trained preventive cardiologist, founder of Flourish Research, chairman of the Family Heart Foundation, and past president of the American Society of Preventive Cardiology, breaks down the major changes in the March 2026 ACC and AHA guideline release. You will hear why LDL targets are explicit again after nearly a decade, why universal lipoprotein A screening is now recommended, why a coronary calcium score above 300 places a patient in the highest-risk treatment tier, and why apolipoprotein B measurement can refine risk assessment when LDL is at goal. Baum also covers the alternatives available when a patient cannot tolerate a statin, including ezetimibe, PCSK9 inhibitors, inclisiran, and bempedoic acid, along with practical framing for the statin-hesitant patient. You will also hear his approach to discussing cholesterol with patients, from the science of lipoprotein physiology to the case for earlier and more aggressive lipid-lowering treatment. Dr. Baum was not compensated for his participation in today's episode. The opinions expressed are his alone and do not represent the opinions of Novartis Pharmaceuticals Corporation. At Novartis, our mission is to ensure no heart is lost too soon. We envision a world where preventable CV deaths are no longer part of our lives. We're proud of the positive impact we've made over the past 40 years and remain dedicated to tackling the most challenging problems in CVD. Through cutting-edge science and technology, we are focusing on areas of high unmet need, including scaling our xRNA platform across multiple risk factors and pioneering breakthroughs for genetically driven CVD risk factors and common heart conditions, including atrial fibrillation. We also work with patients, healthcare professionals, and organizations around the world to improve CV care beyond medicine alone. Together, we can help people with CVD enjoy longer, healthier lives and more time with their loved ones. Learn more here: https://Novartis.us/cardiovascular-disease VISIT SPONSOR → https://Novartis.us/cardiovascular-disease SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Stents, statins, and surgeries don't cure the problem—food does. Hear why lifestyle change is the true intervention. #StatinMyths #HeartFix #LifestyleMedicine #HealthTalks

Calcium Score to Evaluate Arterial Plaque; 50% of Statin Candidates May Not Need Them; Cholesterol Skepticism and Misunderstood Risk; Inflammation as a Key Risk Driver; Combining CRP and LDL for Better Risk Prediction; Why ApoB and Lipoprotein(a) Matter More Than LDL; Patient Case: High Lipoprotein(a) Despite Normal Cholesterol; Understanding Supplements: Red Yeast Rice and Berberine; Niacin: The Disappointing Heart Health Supplement; Amla (Indian Gooseberry) and Simvastatin Comparison; Health = Resilience ÷ Stress; Genetic Variability in Cholesterol Absorption from Food #HeartHealth #Cholesterol #LifestyleMedicine #HealthTalks

On imagine souvent qu'améliorer sa santé cardiovasculaire exige des efforts radicaux : sport intensif, régime strict, transformation totale du mode de vie. Pourtant, une étude récente de la Société européenne de cardiologie vient nuancer cette idée. Publiée le 24 mars 2026 dans l'European Journal of Preventive Cardiology, elle montre qu'il suffit parfois de petits ajustements pour obtenir de vrais bénéfices.Les chercheurs ont suivi plus de 53 000 adultes pendant huit ans, en observant l'évolution de leur santé cardiovasculaire en fonction de leurs habitudes. Leur objectif était simple : comprendre si des améliorations progressives, et non drastiques, pouvaient réellement réduire les risques de maladies du cœur.Le résultat est particulièrement encourageant. Les personnes qui adoptaient même de légères améliorations — par exemple marcher un peu plus chaque jour, réduire légèrement leur consommation d'aliments transformés ou améliorer leur sommeil — voyaient déjà leur risque cardiovasculaire diminuer de manière significative. Autrement dit, il n'est pas nécessaire de devenir un athlète ou de changer radicalement de régime du jour au lendemain.Pourquoi cela fonctionne-t-il ? Parce que la santé cardiovasculaire repose sur une accumulation de facteurs. La pression artérielle, le cholestérol, la glycémie, le poids, mais aussi le niveau d'activité physique et le stress interagissent en permanence. Améliorer ne serait-ce qu'un ou deux de ces paramètres suffit souvent à enclencher une dynamique positive. Par exemple, une activité physique modérée mais régulière peut améliorer à la fois la tension, la circulation sanguine et la sensibilité à l'insuline.L'étude insiste aussi sur un point clé : la progression compte davantage que la perfection. Les participants qui passaient d'un mode de vie défavorable à un mode simplement “moyen” obtenaient déjà des bénéfices importants. Et ceux qui continuaient à progresser, même lentement, voyaient leur risque encore diminuer avec le temps.Ce constat a des implications concrètes. Il rend la prévention beaucoup plus accessible. Plutôt que de viser des objectifs intimidants, il devient plus efficace — et plus réaliste — de se concentrer sur des changements simples : marcher 20 minutes de plus par jour, cuisiner un peu plus souvent, dormir une heure de mieux, ou encore réduire légèrement sa consommation d'alcool.En conclusion, cette étude rappelle une chose essentielle : en matière de santé cardiovasculaire, chaque petit pas compte. Ce ne sont pas les transformations spectaculaires qui font la différence sur le long terme, mais la constance de gestes simples, répétés jour après jour. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

In this episode of the Flex Diet Podcast, I sit down with my good buddy Ari Whitten to talk all about red light therapy (photobiomodulation) and why it's become so popular lately. We dig into how red and near-infrared light fits into an evolutionary sunlight context, why those wavelengths penetrate tissue differently, and how they can influence mitochondria, recovery, and performance.  Ari also breaks down the confusing part most people miss: device choice and dosing aren't one-size-fits-all, and “more power” isn't always better, especially for sensitive areas like facial skin and the eyes. We also get into emerging research on sleep and melatonin (including intracellular melatonin), as well as practical considerations such as clothing and light penetration. Ari's updated book, The Ultimate Guide to Red Light Therapy (2.0), is out now. Sponsors: Daily Fitness Insider Newsletter: https://flex-diet.kit.com/bfa1510fa8 Coming up: ISSN 2026: https://www.sportsnutritionsociety.org/ Available now: Grab a copy of the Triphasic Training II book I co-wrote with Cal Deitz here. Episode Chapters: 04:40 Catching Up Surf Talk 07:34 Sunlight vs Red Light 08:50 Photobiomodulation Basics 11:04 Optical Window Explained 15:41 Timing and Circadian Effects 19:36 Sleep and Melatonin Links 26:00 Clothing and Light Penetration 27:36 Red Light for Eye Health 29:48 Red Light for Eyesight 30:47 Dose and Panel Pitfalls 31:52 Deep vs Superficial Dosing 35:02 Biphasic Response and Safety 38:11 Heuristics for Panel Use 40:46 Choosing the Right Device 42:17 Optics Distance and Angles 44:39 LED Density and Hot Spots 46:47 Device Examples and Timing 48:31 New Book and Wrap Up 53:59 Host Outro and Disclaimer  Flex Diet Podcasts you may enjoy: Episode 352: Mastering Heart Health: A Deep Dive into Preventive Cardiology with Dr. Michael Twyman YouTube: https://www.youtube.com/watch?v=hpdMnJSZMf8 Episode 206: Advanced Recovery Tactics and more with elite athlete coach Justin Kavanauagh YouTube: https://www.youtube.com/watch?v=OTvYT5P3dWs&t=1s Connect with Ari: The Ultimate Guide to Red Light Therapy: https://www.amazon.com/Ultimate-Guide-Light-Therapy-Revised/dp/0593736559?ref_=ast_author_dp Instagram: https://www.instagram.com/ari.whitten/ The Energy Blueprint: https://theenergyblueprint.com/ Get In Touch with Dr Mike: Instagram: Drmiketnelson YouTube: @flexdietcert Email: Miketnelson.com/contact-us

In this episode, Dr Marilena Giannoudi chats with Dr Heeraj Bulluck about preventive cardiology. They discuss the little habits that can make a big difference in preventing heart disease and the importance of taking care of yourself as a doctor as well as the patients you see. Dr Heeraj Bulluck is a UK-based interventional cardiologist with a keen academic interest. Alongside his clinical work, he recently developed an interest in cardiovascular prevention - helping individuals understand and act on risk long before disease develops. He is the author of Heart Reset 40, where he translates clinical insights into practical, sustainable changes for long-term heart health, particularly for busy professionals. Dr Marilena Giannoudi is a cardiology registrar based in Leeds. She is Co-Chair of the Trainees and Members & Committee, a Fellow of the Higher Education Academy, and is currently undertaking a PhD. Recording date: 2 February 2026 --Links-- Heeraj Bulluck, Heart Reset 40 - https://www.amazon.co.uk/Heart-Reset-40-Cardiologists-Science-Backed-ebook/dp/B0G8N4YBPC The Royal College of Physicians of Edinburgh (RCPE) has not quality checked Heart Reset 40 and is not endorsing this resource. A link is provided for reference only. 2025 Update on ESC/EAS Guidelines for management of dyslipidaemias - https://www.escardio.org/guidelines/clinical-practice-guidelines/all-esc-practice-guidelines/dyslipidaemias/ ESC Essential Resources for Preventive Cardiologists - https://www.escardio.org/topics/risk-factors-and-prevention/ -- Follow us -- https://www.instagram.com/rcpedintrainees https://x.com/RCPEdinTrainees -- Upcoming RCPE events -- https://www.rcpe.ac.uk/events -- Become an RCPE Member -- https://www.rcpe.ac.uk/membership/join-college Feedback: cme@rcpe.ac.uk This podcast is from the Trainees & Members' Committee (T&MC) of the Royal College of Physicians of Edinburgh (RCPE).

In this insightful episode of The Better Life, Dr. Pinkston welcomes Dr. Sanjay Bhojraj, a board-certified interventional cardiologist who transitioned from emergency heart procedures to the world of functional and integrative medicine. Dr. Bhojraj shares his "origin story," explaining how a decade of performing "oil changes" on the heart led him to realize that conventional medicine was missing the most critical part of the equation: the mental, emotional, and spiritual lifestyle factors that drive chronic disease. The conversation dives deep into the "lost 20 years" where metabolic issues brew silently before a cardiac event occurs. Dr. Bhojraj introduces his Well12 program, a science-based approach to reversing insulin resistance and inflammation through light optimization, sleep, and whole-food nutrition. They also tackle the modern craze of GLP-1 medications, discussing how to use them as a "slingshot rather than a crutch" by prioritizing muscle preservation and long-term lifestyle shifts.See omnystudio.com/listener for privacy information.

Leyla Muedin, a registered dietician nutritionist, shifts the discussion beyond cholesterol and statins to “hidden” cardiovascular risks from insufficient vitamin K and folate intake. Citing Cleveland Clinic and other research, she notes a high prevalence of vitamin K deficiency in the U.S. and widespread inadequate folate intake globally, including low folate levels among women of reproductive age. She explains that vitamin K2 may help inhibit arterial and soft-tissue calcification via activation of matrix GLA protein, with studies linking higher K2 (MK-7) intake to lower coronary heart disease risk and slowed coronary artery calcification. Folate supports vascular function through homocysteine metabolism, with evidence associating higher folate intake with lower cardiovascular mortality, emphasizing active 5-MTHF over folic acid due to conversion limitations in many people. She also notes statins can downregulate vitamin K metabolism and encourages discussing risks, benefits, and supplements with a doctor.

Simple habits, blood pressure monitoring, and imaging like CAC scans can dramatically reduce risk—test, don't guess. #PreventHeartDisease #LifestyleMedicine #CACScan #EarlyDetection

Jeffrey L. Boone, MD, MS, has been a pioneer in the prevention of heart disease and stroke for over three decades. Dr. Boone is the Founder and Medical Director of the Boone Heart Institute in Denver, Colorado. He has authored and co-authored numerous professional articles and books pertaining to Preventive Cardiology, Cardiometabolic Risk, and Stress Medicine. His book, A World Without Heart Attacks: How We Can Beat Heart Disease – And What Comes Next, will be published in late spring of 2026.Dr. Boone works as a Consultant in Preventive Cardiology for the Denver Broncos and San Francisco 49ers of the NFL, the Colorado Rockies of Major League Baseball, and the Atlanta Hawks of the NBA. Dr. Boone sat of the NFL's Cardiovascular Committee for a decade, and created the NFL Alumni Association's Cardiovascular Screening Program, an ongoing investigation into the cardiovascular health of former NFL players. He is currently the principal investigator of the GAMEFILM Registry, a program Dr. Boone co-created with the HeartFlow corporation to provide free Coronary CT Scans to alumni of the NFL, NBA, and NHL.As an international lecturer, Dr. Boone has spoken to thousands of health care professionals around the world. Dr. Boone's unique clinical approach focuses on aggressive prevention of cardiovascular disease, including unique evaluation of mental stress and the use of the latest cardiac imaging techniques. In recent years, Dr. Boone has begun to explore the implications of his preventive cardiology protocol on brain health and cancer prevention.https://www.booneheart.com/Sponsors:https://waterflyshop.com/mattnappohttps://nextbase.sjv.io/oq1e79https://propmoneyinc.pxf.io/c/3290446...https://vapeworld.evyy.net/c/3290446/...https://eycemolds.pxf.io/c/3290446/16...https://wineexpress.vneoga.net/yqG3E3https://www.dubby.gg/discount/minddog...

With Liemena Harold Adrian, Syarifah Ambami Rato Ebu General Academic Hospital, Surabaya - Indonesia and Shelley Zieroth, St. Boniface Hospital, Winnipeg - Canada.  In this episode, Liemena Harold Adrian and Shelley Zieroth discuss heart failure in post–myocardial infarction patients, covering how myocardial infarction leads to the development of heart failure despite advances in reperfusion and acute care. The conversation addresses the epidemiology and underlying pathophysiology, approaches to early prevention and screening, diagnostic tools, as well as key interventions in the acute and early post-MI phases that may alter heart failure trajectories. They outline management with guideline-directed medical therapy, review current studies on heart failure–modifying therapies (such as the DAPA-MI and EMPACT-MI trials), and address indications for advanced therapies in post-MI populations. The episode also highlights the importance of early diagnosis, prompt recognition, and key evidence gaps in the field. Recommended readings: Akhtar KH, Khan MS, Baron SJ, et al. The Spectrum of Post-Myocardial Infarction Care: From Acute Ischemia to Heart Failurehttps://doi.org/10.1016/j.pcad.2024.01.017. Prog Cardiovasc Dis. (2024); 82: 15-25. DOI: 10.1016/j.pcad.2024.01.017. Butler J, Hammonds K, Talha KM, et al. Incident Heart Failure and Recurrent Coronary Events Following Acute Myocardial Infarctionhttps://doi.org/10.1093/eurheartj/ehae885. Eur Heart J (2025); 46: 1540-50. DOI: 10.1093/eurheartj/ehae885. Butler J, Jones WS, Udell JA. Empagliflozin after Acute Myocardial Infarction. N Engl J Med (2024); 390: 1455-66. DOI: 10.1056/NEJMoa2314051. Fioretti F, Butler J, Udell JA, et al. Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI. ESC Heart Failure (2025); 12: 3940-3952. DOI: 10.1002/ehf2.15393. Hernandez AF, Udell JA, Jones WS. Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial. Circulation (2024); 149: 1627–1638. DOI: 10.1161/CIRCULATIONAHA.124.069217. Jenca D, Melenovsky V, Stehlik J, et al. Heart Failure after Myocardial Infarction: Incidence and Predictors. ESC Heart Failure (2021): 8: 222-237. DOI: 10.1002/ehf2.13144. Lala A, Beavers C, Blumer V, et al. The Continuum of Prevention and Heart Failure in Cardiovascular Medicine: A Joint Scientific Statement from the Heart Failure Society of America and The American Society for Preventive Cardiology. Journal of Cardiac Failure (2026); 32: 75-105. Petrie MC, Udell JA, Anker SD, et al. Empagliflozin in Acute Myocardial Infarction in Patients with and without Type 2 Diabetes: A Pre-specified Analysis of the EMPACT-MI Trial. Eur J of Heart Fail. (2025): 27: 577-588. DOI: 10.1002/ejhf.3548. Zieroth S, Rizi SS. Time Is of the Essence. JACC: Heart Failure (2023): 11(6): 713-714. DOI: 10.1016/j.jchf.2023.03.022 "This 2026 HFA Cardio Talk podcast series is supported by Bayer in the form of unrestricted financial support. The discussion has not been influenced in any way by its sponsors."

Heart disease should be treated just like cancer, says guest Mike McConnell, an author and expert in preventive cardiology at Stanford: Detect and stage early, then treat aggressively. In his practice, McConnell focuses on using low-dose CT imaging for detecting early coronary artery disease. He also helped pioneer the use of AI to infer cardiovascular risk from retinal scans. Such non-invasive, consumer-friendly tools could expand prevention, personalize therapy, and cut heart attacks and strokes across the board, he says. “Everybody also deserves a proactive preventive cardiologist in their phone,” McConnell tells host Russ Altman of the latest approaches to heart disease on this episode of Stanford Engineering's The Future of Everything podcast. Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu. Episode Reference Links: Stanford Profile: Michael V. McConnell, MD, MSEE Connect With Us: Episode Transcripts >>> The Future of Everything Website Connect with Russ >>> Threads / Bluesky / Mastodon Connect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / Facebook Chapters: (00:00:00) Introduction Russ Altman introduces guest Michael McConnell, a professor of cardiology at Stanford University. (00:03:02) Reframing Heart Disease Why coronary disease should be approached the same as cancer. (00:05:46) Core Risk Factors The key drivers of cardiovascular disease, and life's essential eight. (00:07:18) Coronary Artery Calcium Scoring How low-dose CT scanning detects disease before symptoms develop. (00:08:57) The Limits of Stress Testing Why traditional stress tests often miss early coronary disease. (00:10:18) AI in Cardiac Imaging Using AI to identify hidden risks in routine chest scans. (00:11:30) Retinal Imaging How AI analysis of retinal blood vessels can predict heart disease risk. (00:14:55) Detecting Risk Before Symptoms Why retinal and vascular changes occur long before clinical signs appear. (00:15:58) Staging Coronary Disease Using calcium scores to stage coronary disease and personalize treatment. (00:19:36) Direct-to-Consumer Prevention The rise of mobile health records, wearable devices, and AI tools. (00:22:23) Opportunities & System Challenges Balancing accessibility, guideline-based care, and healthcare system capacity. (00:25:26) AI-Powered Health Record Analysis The potential of automated reviews to identify silent risk factors. (00:27:41) Physician Adoption & System Friction Barriers to integrating early detection tools into clinical practice. (00:30:12) Advances in Treatment Overview of current cholesterol therapies and plaque stabilization. (00:33:31) Future In a Minute Rapid-fire Q&A: prevention, implementation science, and future hopes. (00:35:38) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Heart Heath with Heather Johnson, M.D., cardiologist and director of Preventive Cardiology for Women's Services at Baptist Health Heart & Vascular Care at Baptist Health Christine E. Lynn Women's Health & Wellness InstituteSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Understanding and Managing Heart Health: In this Heart Health Month episode of the Intelligent Medicine Podcast, nutritionist Leyla Muedin addresses a listener's question about elevated cholesterol levels and calcium scores. Drawing on an article written by Dr. Hoffman, she emphasizes the importance of discussing statin use with a doctor, considering individual risk factors, and getting additional tests like VAPs, NMR, homocysteine, and lipoprotein levels. The episode explores the importance of vitamins K2 and folate in cardiovascular health, addressing nutritional deficiencies, and the impact of dietary choices on heart health.

If you're wondering what your coronary artery disease risk really is, a calcium score screening can provide important insight—often before symptoms appear. In this episode of Baptist Health Talk, host Willard Shepherd speaks with Dr. Socrates Kakoulides, cardiologist and Chief Imaging Officer at Baptist Health, to explain what a calcium score measures, who should consider the test, and how it fits into overall heart health.You'll learn how calcium scores are used to assess heart attack and stroke risk, why age matters when interpreting results, and how lifestyle changes and medical therapy can significantly improve long-term outcomes. Dr. Kakoulides also clears up common misconceptions about calcium and shares practical steps for protecting your heart through diet, sleep, exercise, and stress management.

Managing heart failure isn't just about medications. It's about the everyday food choices that can either ease the strain on your heart or quietly make symptoms worse.In this episode, we break down why sodium has such a powerful impact on heart failure, how it drives fluid retention and shortness of breath, and why even small changes can lead to noticeable relief within days. You'll learn how to spot hidden sodium in common foods, what to eat instead, and how to build meals that support your heart without feeling restrictive or bland.We also explore simple, realistic nutrition strategies for real life, from eating well when energy is low or appetite is poor, to using flavor-forward ingredients that make low-sodium meals satisfying and sustainable. Whether you're living with heart failure, supporting a loved one, or trying to protect your heart long-term, this conversation offers practical, evidence-based guidance you can start using right away.Guest Bio:Julia Zumpano has been a registered dietitian with Preventive Cardiology and Rehabilitation at the Cleveland Clinic for 20 years. Her time in patient care is spent counseling on a cardio-protective diet, with focus on lipid, hypertension, diabetes, and weight management. She also serves as the Nutrition Media Liaison, where she manages the media requests to the outpatient Nutrition Therapy department, played an integral role in the development of the Cleveland Clinic diet app, and is the co-host of the Nutrition Essentials Podcast.“Simplify what you're consuming. Keep it very simple. Do what's with whatever is in your means, but if you are able to commit, let's say, three or four days to a low-sodium diet, you may find that you'll be able to get rid of some of that fluid you're retaining.” Question of the Day:What are some tips you use in your kitchen to make meals more flavorful without adding that extra sodium?On This Episode You Will Learn:Why sodium plays such a critical role in heart failure management, including what happens in the body when intake is too high and how it contributes to fluid buildup and worsening symptoms.How sodium affects blood pressure and heart function, why this added strain is especially dangerous for people with heart failure, and how even small reductions can lead to noticeable symptom relief.Common high-sodium foods that often go unnoticed, from packaged staples to restaurant meals, and practical tips for identifying hidden sodium on labels.What to eat for a stronger heart, highlighting staple ingredients and eating patterns that support fluid balance, reduce symptoms, and help meet nutrient needs even when appetite or energy is low.Making low-sodium eating realistic and enjoyable, with strategies to preserve flavor, honor food traditions, and build sustainable habits that support long-term heart health.Connect with Yumlish!Yumlish Website: YumlishYumlish on Instagram: @yumlish_Yumlish on Facebook: YumlishYumlish on Twitter: @yumlish_Yumlish on LinkedIn: YumlishConnect with Julia Zumpano!LinkedIn: https://www.linkedin.com/in/zumpano-julia-4757482a Nutrition Essentials Podcasts: https://www.youtube.com/playlist?list=PLMG0zKOgNqNmoVhXKP1zvIuFS5BcVXJyG

In this episode of IDEA Collider, host Mike Rea speaks with Dr. Sekar Kathiresan, founder of Verve Therapeutics and now part of Eli Lilly, about one of the boldest ideas in modern medicine: using one-time gene editing to permanently lower cholesterol and prevent heart disease.Dr. Kathiresan shares his journey from immigrant upbringing to Harvard cardiologist, genetic researcher, biotech founder, and now leader inside a global pharmaceutical company. The conversation explores how human genetics, CRISPR base editing, lipid nanoparticle delivery, and asymmetric learning converged to create a potential lifelong solution to cardiovascular disease.They also dive deep into the ethics of gene editing, global access and pricing, early intervention versus chronic care, FDA regulatory challenges, and what the Verve–Lilly acquisition means for the future of cardiometabolic medicine.This episode is a must-listen for anyone interested in biotech innovation, gene therapy, cardiovascular disease, and the future of preventive medicine. 00:00 Introduction and Guest Welcome01:16 Sekar Kathiresan's Early Life and Education03:19 Founding Verve and Transition to Entrepreneurship05:35 The Science Behind Verve's Mission10:27 Challenges and Breakthroughs in Gene Editing20:05 Regulatory Hurdles and First Human Trials25:11 Ethical Considerations in Gene Editing27:06 Introduction to Drug Delivery and Ethical Considerations27:51 Historical Context and Pioneers in Medical Procedures28:35 Commercial and Ethical Challenges in Medicine29:32 Innovations in Cardiovascular Treatments32:49 The Role of Gene Editing in Long-term Health37:55 Strategic Partnerships and Industry Insights45:08 Reflections on the US Medical Ecosystem48:54 Conclusion and Future Outlook Keep up with Sekar Kathiresan;LinkedIn: https://www.linkedin.com/in/sekar-sek-kathiresan-3501846/Website: https://www.lilly.com/ Follow Mike Rea On;Website: https://www.ideapharma.com/X: https://x.com/ideapharmaLinkedIn: https://www.linkedin.com/in/bigidea/ Listen to more fantastic podcast episodes: https://ideacollider.simplecast.com/ 

We welcome Dr. Sunny Intwala, a leading preventive cardiologist with Northwell Health in the Hudson Valley, specializing in cholesterol management, cardiac imaging and heart-disease prevention. Ray Graf hosts.

In the latest episode of Parallax, Dr Ankur Kalra welcomes Dr Martha Gulati and Dr Anu Lala for a groundbreaking conversation about reimagining heart failure prevention across the entire disease spectrum. Their discussion centres on an innovative scientific statement developed collaboratively between the American Society of Preventive Cardiology and the Heart Failure Society of America - a document that challenges conventional approaches to cardiovascular disease prevention. Dr Gulati and Dr Lala make a compelling case for expanding prevention beyond atherosclerotic cardiovascular disease (ASCVD) to encompass heart failure, a condition affecting one in four individuals over their lifetime. They introduce the American Heart Association's Cardio Kidney Metabolic (CKM) health framework as a superior model for identifying at-risk patients, explaining how this approach shifts focus from disease management to health optimization. The conversation explores practical implementation strategies, including the new PREVENT risk score, which integrates critical heart failure risk factors like obesity and chronic kidney disease that traditional assessment tools overlook. Questions and comments can be sent to "podcast@radcliffe-group.com" and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.

Dr. Jack Wolfson, known as “The Paleo Cardiologist,” joins hosts Drs. Tim & May Hindmarsh on the BS Free MD podcast to discuss his pivot from traditional hospital-based cardiology into a holistic, cause-based model of heart health. He shares how his personal and professional experiences led him to challenge the status quo—shifting focus from symptomatic treatment (eg. stents, statins) to underlying causes such as diet, toxins, lifestyle and stress. The conversation explores how a paleo-inspired, whole-food nutrition model, combined with environmental awareness and lifestyle changes, can meaningfully transform cardiovascular risk and patient outcomes.ABOUT THE GUESTDr. Jack Wolfson, DO, FACC, is a board-certified cardiologist, bestselling author of The Paleo Cardiologist: The Natural Way to Heart Health, and founder of Natural Heart Doctor, a holistic cardiology practice based in Arizona. After years in traditional hospital cardiology, he transitioned to a root-cause approach emphasizing nutrition, toxin reduction, and lifestyle medicine. Dr. Wolfson has been featured on CNN, Fox News, NBC, and The Dr. Oz Show, and he continues to educate the public on preventing cardiovascular disease through natural, science-backed methods.Website: https://naturalheartdoctor.comInstagram: @drjackwolfsonGET SOCIAL WITH US!

Dr. Hoffman continues his conversation with Dr. Alan Rozanski, a distinguished Professor of Medicine at the Icahn School of Medicine at Mount Sinai and Director of Nuclear Cardiology at Mount Sinai St. Luke's in New York City.

Dr. Alan Rozanski, a distinguished Professor of Medicine at the Icahn School of Medicine at Mount Sinai and Director of Nuclear Cardiology at Mount Sinai St. Luke's in New York City, details the holistic aspects of medicine, emphasizing the integrative approach involving lifestyle, mental health, exercise, and the psychological dimensions of heart health. Dr. Rozanski reveals the six domains of optimal health and vitality, sharing insights from his pioneering work in integrating such approaches into cardiology, the significant impact of stress, and the importance of maintaining a sense of life purpose and social connections. He also delves into modern imaging techniques, the utility of coronary artery calcium scores, and emerging treatments like GLP-1 drugs for cardiovascular health. The conversation provides a thorough exploration of comprehensive health management strategies beyond just medication and surgery.

Subscribe to our channel:    / @optispan  Get Our Newsletter (It's Free): https://www.optispan.life/Join me for an in-depth conversation with Dr. Alex and Dr. Jan from the YEARS Healthspan Clinic in Berlin. They pull back the curtain on what a truly evidence-based, scientific approach to longevity medicine looks like, moving beyond the hype and "snake oil" to focus on rigorous diagnostics, personalized interventions, and the critical collection of high-quality data.In this episode, they delve into the comprehensive 6+ hour diagnostic workup I am about to undergo, discuss the hierarchy of interventions (from lifestyle as the foundation to the careful use of pharmaceuticals), and debate the role of supplements, peptides, and more experimental therapies. This is a masterclass in the practical application of healthspan medicine from leading clinicians in the field.This video was produced by One Billion Media, an agency that specializes in YouTube virality for health brands and experts. Learn more about their work here:https://onebillionmedia.com/Timestamps:00:00 – Trailer01:12 – Introduction02:19 – Inside the 6-Hour Health Assessment05:00 – Full-Body MRI & Advanced Testing11:57 – Biological Age Tests & Organ-Specific Clocks17:10 – "Scientific Healthspan" vs. Longevity Medicine25:50 – Reversing Type 2 Diabetes: A Real-World Case31:42 – Supplements: Separating Facts from Fads43:20 – Rapamycin, GLP-1s & Metformin: What's Proven?54:00 – Muscle Loss, Brain Health & Alzheimer's Prevention01:05:11 – Stem Cells, Exosomes & Peptides: Hype or Hope?01:12:57 – No Shortcuts: The Need for Clinical Trials01:17:47 – Preventive Cardiology & Lipid Management01:26:52 – Hormone Therapy: Men, Women & Misconceptions01:33:12 – The Longevity Field's Biggest Problem01:39:05 – "Dr. ChatGPT" & The Self-Diagnosis Dilemma01:43:14 – Why Healthcare Must Change Now01:45:26 – Closing ThoughtsDISCLAIMER: The information provided on the Optispan podcast is intended solely for general educational purposes and is not meant to be, nor should it be construed as, personalized medical advice. No doctor-patient relationship is established by your use of this channel. The information and materials presented are for informational purposes only and are not a substitute for professional medical advice, diagnosis, or treatment. We strongly advise that you consult with a licensed healthcare professional for all matters concerning your health, especially before undertaking any changes based on content provided by this channel. The hosts and guests on this channel are not liable for any direct, indirect, or other damages or adverse effects that may arise from the application of the information discussed. Medical knowledge is constantly evolving; therefore, the information provided should be verified against current medical standards and practices.More places to find us:Twitter: https://x.com/Optispan_IncTwitter:   / mkaeberlein  Linkedin:   / optispan  Instagram:   / optispan_  TikTok:   / optispan  https://www.optispan.life/Hi, I'm Matt Kaeberlein. I spent the first few decades of my career doing scientific research into the biology of aging, trying to understand the finer details of how humans age in order to facilitate translational interventions that promote healthspan and improve quality of life. Now I want to take some of that knowledge out of the lab and into the hands of people who can really use it.On this podcast I talk about all things aging and healthspan, from supplements and nutrition to the latest discoveries in longevity research. My goal is to lift the veil on the geroscience and longevity world and help you apply what we know to your own personal health trajectory. I care about quality science and will always be honest about what I don't know. I hope you'll find these episodes helpful!

Dr. Hoffman continues his conversation with Jim LaValle, a clinical pharmacist and certified clinical nutritionist, detailing cholesterol's importance and its implications for cardiovascular health. 

September is Cholesterol Education Month. In this episode of Intelligent Medicine, Jim LaValle, a clinical pharmacist and certified clinical nutritionist, details cholesterol's importance and its implications for cardiovascular health. He delves into the nuances of cholesterol types, the historical shifts in perceptions of cholesterol, and how dietary and lifestyle factors influence cholesterol levels and cardiovascular risk. Jim provides expert insights into the roles of LDL and HDL cholesterol, the significance of cholesterol particle size, the impact of carbohydrates on cholesterol, and the benefits of aged garlic extract and other supplements. The conversation emphasizes the importance of comprehensive lipid testing, understanding individual risk factors, and integrating both lifestyle modifications and, when necessary, medications into cardiovascular preventive strategies. The episode concludes with a discussion on the role of health policies and the future of integrative health approaches.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-448 Overview: Join us to discover how flavan-3-ols, found in tea, cocoa, and select fruits, can support cardiovascular prevention. Learn how to translate emerging evidence on blood pressure and vascular health into practical dietary guidance that empowers your patients and complements standard hypertension care. Episode resource links: European Journal of Preventive Cardiology (2025) 00, 1–13. https://doi.org/10.1093/eurjpc/zwaf173 Guest: Robert A. Baldor MD, FAAFP   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-448 Overview: Join us to discover how flavan-3-ols, found in tea, cocoa, and select fruits, can support cardiovascular prevention. Learn how to translate emerging evidence on blood pressure and vascular health into practical dietary guidance that empowers your patients and complements standard hypertension care. Episode resource links: European Journal of Preventive Cardiology (2025) 00, 1–13. https://doi.org/10.1093/eurjpc/zwaf173 Guest: Robert A. Baldor MD, FAAFP   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

In this week's Flex Diet Podcast, I sit down with fitness expert Bryan Boorstein to dig into the idea of “Meathead Cardio.” Brian has been in the lifting world for years, but over time, he began adding more cardio into his routine—and not only did it stick, it actually improved his performance and health. We talk about why hybrid training isn't the enemy of muscle, how to balance lifting and cardio without wrecking recovery, and the strategies Brian used to hold onto his muscle while ramping up his endurance work. He also shares his experience training for and excelling in endurance events, and how this shift has changed his overall well-being. We wrap up with some practical advice on how you can fold more cardio into your training without sacrificing strength, plus a look ahead at where training and tech might collide in the future. Sponsors:Beyond Power Voltra 1: https://www.beyond-power.com/michael13PNOE - tell them Dr Mike T sent ya: https://pnoe.comKillswitch for sleep: https://www.switchsupplements.com/DRMIKE use code DRMIKE to save $$Available now:Grab a copy of the Triphasic Training II book I co-wrote with Cal Deitz here.Episode Chapters:04:25 Brian's Hybrid Training Journey04:59 Balancing Lifting and Cardio08:49 Training Adjustments and Experiments14:16 Low Volume Training and Maintenance34:16 Cardio's Impact on Aesthetics and Well-being40:24 Brian's Cardio Training Regimen44:50 Significant Improvements in Rowing Performance45:32 Balancing Training and Recovery45:56 Adapting Training for Seasonal Changes47:15 Experimenting with Different Workout Routines48:25 Incorporating Cardio and Flexibility49:31 The Importance of Diverse Physical Activities51:41 Cardiovascular Training Setup55:49 The Role of Technology in Training01:05:16 Running and Its Impact on Training01:09:21 Zone Two Training and Recovery01:14:48 Conclusion and Final ThoughtsFlex Diet Podcast Episodes You May Enjoy: Episode 220: Lessons in Muscle Size From Training One Arm for Weeks – an interview with Bryan Boorstein, https://youtu.be/xKpqpybuTE8 Episode 252: Mastering Heart Health: A Deep Dive into Preventive Cardiology with Dr. Michael Twyman, https://youtu.be/hpdMnJSZMf8Connect with Bryan:Instagram: https://www.instagram.com/bryanboorsteinWebsite: https://evolvedtrainingsystems.comGet In Touch with Dr Mike:Instagram: DrmiketnelsonYouTube: @flexdietcertEmail: Miketnelson.com/contact-us

Join Dr. Philip Ovadia and Practice Manager Cherish Thompson for a compelling conversation on cardiovascular disease (CVD) and the path to restoring health and quality of life. They'll explore the importance of early diagnostics, working with a cardiothoracic surgeon, and addressing key factors like metabolic health, LDL cholesterol, and lifestyle changes. Gain valuable insights into tackling heart disease and making impactful changes to achieve long-term wellness.Send Dr. Ovadia a Text Message. (If you want a response, you must include your contact information.) Dr. Ovadia cannot respond here. To contact his team, please send an email to team@ifixhearts.com Like what you hear? Head over to IFixHearts.com/book to grab a copy of my book, Stay Off My Operating Table. Ready to go deeper? Talk to someone from my team at IFixHearts.com/talk.Stay Off My Operating Table on X: Dr. Ovadia: @iFixHearts Jack Heald: @JackHeald5 Learn more: Stay Off My Operating Table on Amazon Take Dr. Ovadia's metabolic health quiz: iFixHearts Dr. Ovadia's website: Ovadia Heart Health Jack Heald's website: CultYourBrand.com Theme Song : Rage AgainstWritten & Performed by Logan Gritton & Colin Gailey(c) 2016 Mercury Retro RecordingsAny use of this intellectual property for text and data mining or computational analysis including as training material for artificial intelligence systems is strictly prohibited without express written consent from Dr. Philip Ovadia.

CardioNerds (Drs. Rick Ferraro and Georgia Vasilakis Tsatiris) discuss ATTR cardiac amyloidosis with expert Dr. Justin Grodin. This episode is a must-listen for all who want to know how to diagnose and treat ATTR with current available therapies, as well as management of concomitant diseases through a multidisciplinary approach. We take a deep dive into the importance of genetic testing, not only for patients and families, but also for gene-specific therapies on the horizon. Dr. Grodin draws us a roadmap, guiding us through new experimental therapies that may reverse the amyloidosis disease process once and for all.  Audio editing by CardioNerds academy intern, Christiana Dangas. This episode was developed in collaboration with the American Society of Preventive Cardiology and supported by an educational grant from BridgeBio.  Enjoy this Circulation Paths to Discovery article to learn more about the CardioNerds mission and journey.  US Cardiology Review is now the official journal of CardioNerds! Submit your manuscripts here.  CardioNerds Cardiac Amyloid PageCardioNerds Episode Page Pearls: You must THINK about your patient having amyloid to recognize the pattern and make the diagnosis. Start with a routine ECG and TTE, and look for a disproportionately large heart muscle with relatively low voltages on the ECG.  Before you diagnose ATTR amyloidosis, AL amyloidosis must be ruled out (or ruled in) with serum light chains, serum/urine immunofixation, and/or tissue biopsy.  Genetic testing is standard of care for all patients and families with ATTR amyloidosis, and the future is promising for gene-specific treatments. Current FDA-approved treatments for TTR amyloidosis are TTR stabilizers and TTR silencers, but TTR fibril-depleting agents are on their way.  Early diagnosis of ATTR affords patients maximal benefit from current amyloidosis therapies.   TTR amyloidosis patients require a multidisciplinary approach for success, given the high number of concomitant diseases with cardiomyopathy.  Notes: Notes: Notes drafted by Dr. Georgia Vasilakis Tsatiris.  What makes you most suspicious of a diagnosis of cardiac amyloidosis from the typical heart failure patient?  You must have a strong index of suspicion, meaning you THINK that the patient could have cardiac amyloidosis, to consider it diagnostically. Some characteristics or “red flags” to not miss:   Disproportionately thick heart muscle with a relatively low voltages on EKG   Bilateral carpal tunnel syndrome – estimated that 1 in 10 people >65 years old will have amyloidosis   Previously tolerated antihypertensive medications  Atraumatic biceps tendon rupture   Bilateral carpal tunnel syndrome  Spinal stenosis   Concomitant with other diseases: HFpEF, low-flow low-gradient aortic stenosis  How would you work up a patient for cardiac amyloidosis?   Start with a routine ECG (looking for disproportionally low voltage) and routine TTE (looking for thick heart muscle)  CBC, serum chemistries, hepatic function panel, NT proBNP, and troponin levels  NOTE: It is critical to differentiate between amyloid light chain (AL amyloidosis) and transthyretin ATTR amyloidosis, as both make up 95-99% of amyloidosis cases.   Obtain serum free light chains, serum & urine electrophoresis, and serum & urine immunofixation to rule out AL amyloidosis. (See table below)  AL Amyloidosis ATTR Amyloidosis  → Positive serum free light chains and immunofixation (Abnormal M protein) → Tissue biopsy (endomyocardial, fat pad) to confirm diagnosis → Negative serum free light chains and immunofixation (ruled out AL amyloidosis) → Cardiac scintigraphy (Technetium pyrophosphate with SPECT imaging)  What treatment options do we have to offer now for ATTR CM, and how has this compared to prior years?   Before 2019, treatment options were limited outside of cardiac tr...

Send us a textThis week's expert interview is with Dr. Emily Andaya, Medical Director of the Cardiovascular Program at Major Health Partners of Shelbyville, IN. She joins Louise Campbell and Roger Green to discuss the American Heart Assocation's CKM initiative, why she believe it should be titled "CKLM" for liver, and how including liver in the CKM scoring system would make it stronger and provide a more robust tool to help improve patients' health. Emily begins by discussing her attendance at the American Society for Preventive Cardiology meeting in Boston the previous weekend, where Dr. Christos Montzoros presented a talk proposing that the liver's role in cardiovascular diseases is "equally critical" compared to the kidney and other multi-metabolic co-morbidities. Dr. Montzoros closed his talk by stating that the CKM syndrome description should be changed to CKLM to reflect the importance of the liver, and that the CKLM patient scoring and criteria should reflect this as well.Next, Emily describes the 0-to-4 scoring system that the CKM initiative has chosen to use and the recommendations that accompany the scoring system itself. The system does not neatly overlay the 4-point fibrosis scoring system or the NAS score, but Emily describes how these might be incorporated into the CKM score. The conversation shifts to focus on patient management. Since the original CKM paper was published in 2023, resmetirom had not yet been approved and the paper itself focused more on screening than on treatment. To Emily, adding the "L" to CKM would entail adding resmetirom to treatment protocols as appropriate, and also considering drug combinations that addressed liver disease. Louise takes this issue from the other side, suggesting that every time a provider prescribes a drug to a CKM patient, the potential for negative liver effects should be part of the selection process. Emily and Louise agree that providers and patients should take a holistic approach to therapy for these patients. One benefit: even if a patient has multiple organs affected by multi-metabolic challenges, the provider can educate the patient that there is a single target disease to treat instead of multiple different diseases. As Roger notes, treating 4-5 discrete diseases simultaneously sounds overwhelming, while treating one overarching disease sounds far more manageable.The conversation ends with a focus on whether we are correctly identifying high-risk cardiovascular patients in the current environment, and how this more holistic focus might improve patient screening and identification.

Join heart surgeon Dr. Philip Ovadia and his clinical team to learn how you can prevent heart attacks. We'll dive in to lab work, CACs, what to do when your PCP is pushing unwanted drugs, and which numbers really make the difference.Send Dr. Ovadia a Text Message. (If you want a response, you must include your contact information.) Dr. Ovadia cannot respond here. To contact his team, please send an email to team@ifixhearts.com Like what you hear? Head over to IFixHearts.com/book to grab a copy of my book, Stay Off My Operating Table. Ready to go deeper? Talk to someone from my team at IFixHearts.com/talk.Stay Off My Operating Table on X: Dr. Ovadia: @iFixHearts Jack Heald: @JackHeald5 Learn more: Stay Off My Operating Table on Amazon Take Dr. Ovadia's metabolic health quiz: iFixHearts Dr. Ovadia's website: Ovadia Heart Health Jack Heald's website: CultYourBrand.com Theme Song : Rage AgainstWritten & Performed by Logan Gritton & Colin Gailey(c) 2016 Mercury Retro RecordingsAny use of this intellectual property for text and data mining or computational analysis including as training material for artificial intelligence systems is strictly prohibited without express written consent from Dr. Philip Ovadia.

In this conversation, Dr. Elizabeth Klodas, a preventive cardiologist and founder of Step One Foods, discusses the critical role of nutrition in managing heart disease and the challenges faced in integrating dietary changes into medical practice. She shares her journey from traditional medicine to creating a food company aimed at reducing reliance on medications through nutrition. The discussion highlights the importance of randomized controlled trials in validating the effectiveness of food-based interventions, the impact of pharmaceuticals on healthcare, and the need for a shift in consumer perceptions towards whole food ingredients. Dr. Klodas emphasizes the potential for a healthier future where cardiologists are less needed due to preventive measures and lifestyle changes.Takeaways:Nutrition is often overlooked in favor of pharmaceuticals in healthcare.Patients are rarely asked about their diet by healthcare providers.Changing dietary habits can lead to significant health improvements.Pharmaceuticals are easier to prescribe than dietary changes.There is a lack of nutrition education in medical training.Step One Foods aims to fill nutritional gaps in patients' diets.Randomized controlled trials can validate the effectiveness of food products.Consumer perceptions of health foods can be influenced by marketing.The food industry often prioritizes cost over nutrition.A better world would mean fewer cardiologists needed due to preventive health measures.Sound bites:“There is very little to no nutrition education for physicians. As I look back on this I consider this educational malpractice.”“All the medical evidence of what we should be doing is very heavily pharma biased, because guidelines are based on randomized control clinical trials.”“So there's loads of reasons why nutrition is not used in clinical care the way it should be. None of that is an excuse though, because it works and it's so vital.”“What if I asked you to like eat this food twice a day and I otherwise left you alone? What started happening is people calling and saying, hey, my cholesterol dropped 39 points. Then I'm like, okay, we're gonna subject our products to a randomized control trial. Let's see. Let's prove it. Does this actually work?”“If I reduce, LDL, the bad cholesterol across the US population by an average of 9%, I will finally dethrone heart disease as our number one killer.”“In that trial, we replicated what people were calling in with our highest LDL reduction was close to 40 % in 30 days. That's a medication level cholesterol reduction. And we did that with food, without turning people's lives upside down.”“It's not just the nutrient of interest that's important. It's the delivery vehicle. You can stuff a bunch of fiber into a Twinkie. But in the end, you're still eating a Twinkie, right? Food and nutrition is complex.”“At Step One Foods I take the complexity out for people. I take whole food ingredients, each and every single one that has data behind it in terms health benefits, and put them in my foods.”“We are probably the most overfed and undernourished society in the history of our species.”“If you truly believe in your mission, you have to ignore all the no's.”Promo Offer:Code: BETTERWORLDLink: https://www.steponefoods.com/discount/BETTERWORLDOffer: 10% off first order for both one time and subscription orders. Offer can be stacked with the subscription discount to save 30% on their first order. Exclusions: Limited to one use per customer. Limited to a customer's first order and only applies to the first recurring order. Code must be entered at checkout for the discount to be applied. Links:Dr Elizabeth Klodas on LinkedIn - https://www.linkedin.com/in/eklodas/Step One Foods- https://www.steponefoods.com/Step One Foods on LinkedIn - https://www.linkedin.com/company/steponefoods/Step One Foods on Facebook - https://www.facebook.com/StepOneFoodsStep One Foods on Instagram - https://www.instagram.com/steponefoods/Step One Foods on YouTube - https://www.youtube.com/StepOneFoods…“Slay the Giant: The Power of Prevention in Defeating Heart Disease” book - https://www.steponefoods.com/products/slay-the-giant…Brands for a Better World Episode Archive - http://brandsforabetterworld.com/Brands for a Better World on LinkedIn - https://www.linkedin.com/company/brand-for-a-better-world/Modern Species - https://modernspecies.com/Modern Species on LinkedIn - https://www.linkedin.com/company/modern-species/Gage Mitchell on LinkedIn - https://www.linkedin.com/in/gagemitchell/…Print Magazine Design Podcasts - https://www.printmag.com/categories/printcast/…Heritage Radio Network - https://heritageradionetwork.org/Heritage Radio Network on LinkedIn - https://www.linkedin.com/company/heritage-radio-network/posts/Heritage Radio Network on Facebook - https://www.facebook.com/HeritageRadioNetworkHeritage Radio Network on X - https://x.com/Heritage_RadioHeritage Radio Network on Instagram - https://www.instagram.com/heritage_radio/Heritage Radio Network on Youtube - https://www.youtube.com/@heritage_radioChapters:03:00 Introduction to Preventive Cardiology and Nutrition05:58 The Shift from Nutrition to Medication in Healthcare08:45 The Role of Pharmaceuticals in Patient Care11:41 The Challenges of Nutrition Education in Medicine14:41 The Complexity of Food and Nutrition Science17:59 Step One Foods: A New Approach to Nutrition20:57 The Impact of Randomized Controlled Trials on Nutrition23:59 The Importance of Ingredient Quality in Food Products26:49 Pushback from the Medical and Food Industries29:52 The Insurance Industry's Role in Healthcare Costs32:52 Step One Foods: Product Overview and Benefits38:43 Introduction to Whole Foods and Health Claims40:56 The Importance of Real Ingredients42:56 Navigating Organic Ingredients and Supply Chain Challenges44:59 Stepwise Approach to Health and Nutrition48:58 Challenges in Scaling Food Production51:49 Milestones and Industry Changes56:55 Advice for Aspiring Food Entrepreneurs59:50 Personal Indulgences and Food Preferences01:03:00 Innovative Thinkers in Nutrition01:05:50 Vision for a Healthier WorldSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Heart disease is the leading cause of death for women—yet it's still treated like a man's disease. In this powerful conversation, Dr. Martha Gulati, a cardiologist and pioneer in women's cardiovascular health, exposes the systemic gaps that leave women underdiagnosed, undertreated, and often unheard. Together, we unpack the critical differences in how heart disease presents in women, why standard diagnostic tools fall short, and what every woman needs to know about risk factors like pregnancy complications, hormone therapy, statin use, and even environmental exposures. Dr. Gulati also reveals the truth behind hormone therapy myths, explains how soft plaque really forms, and why fitness should be considered frontline prevention.You'll learn:Why women's heart symptoms are often mistaken for anxietyWhat tests to ask for to asses your risk of heart disease How statins, hormone therapy, and fitness interact with riskWhat the new “Prevent" risk score includes—and why it mattersWhy women get more benefits from exercise than menHow pollution, stress, and pregnancy complications shape long-term riskWhether you're in your 20s or postmenopausal, this episode will empower you to take charge of your heart health, ask better questions, and get the care you deserve.Who is Dr. Martha Gulati?Dr. Martha Gulati is a professor of cardiology at the Smidt Heart Institute at Cedars-Sinai, where she serves as Director of Prevention and Associate Director of the Barbra Streisand Women's Heart Center. She is the immediate past president of the American Society for Preventive Cardiology and previously served as the inaugural Chief of Cardiology at the University of Arizona. A leading voice in women's heart health, Dr. Gulati chaired the first national chest pain guidelines and is the author of the best-selling book Saving Women's Hearts.This episode is brought to you by: Manukora - Get $25 off the starter kit – https://manukora.com/DRLYON ARMRA – Code DRLYON for 15% off your first order – https://tryarmra.com/DRLYON Masa Chips - Code LYON for 25% off your first order – https://masachips.com/LYON Our Place – Code DRLYON for 10% off sitewide – https://fromourplace.com/DRLYON Find Dr. Martha Gulati At: Website - https://drmarthagulati.com/ LinkedIn - https://www.linkedin.com/in/martha-gulati-9b410496/Instagram - https://www.instagram.com/drmarthagulati/X/Twitter - https://x.com/drmarthagulatiCedars-Sinai - https://www.cedars-sinai.org/provider/martha-gulati-2036029.htmlHer book Saving Women's Hearts: https://www.amazon.ca/Saving-Womens-Hearts-Conventional-Strategies/dp/0470678453 Find Me At: Instagram:

If you're anything like me, you've probably looked back and thought, “Why didn't I know this 10 years ago?” That's exactly what today's chat is about - my top five health game-changers I wish I had embraced earlier. Whether you're 25 or 75, these insights can shift the needle in how you feel, look, and thrive. From nutrition tracking without guilt to finally getting that high-quality protein in, these tips aren't about restriction - they're about empowerment. I'm opening up about what's worked, what didn't, and why strength training, ditching the processed stuff, and even allowing yourself to be hungry can be revolutionary. This one is packed with real-life examples, scientific backing, and simple steps to get started without getting overwhelmed. What we're tackling: Track your food with intention, not shame. Ditch skinny, build strong with progressive overload. Prioritize protein without obsessing. Phase out processed foods gradually. Embrace hunger and stop snacking aimlessly. Meditation App : Simply Being App Get Weekly Health Tips:  thrivehealthcoachllc.com Let's Connect:@‌ashleythrivehealthcoach or via email: ashley@thrivehealthcoachingllc.com Podcast Produced by Virtually You! Sources: Tracking Nutrition Burke, L. E., Wang, J., & Sevick, M. A. (2011). Self-monitoring in weight loss: A systematic review of the literature. Journal of the American Dietetic Association, 111(1), 92–102. https://doi.org/10.1016/j.jada.2010.10.008 Raber, M., Patterson, M., & Jia, W. (2021). A systematic review of the use of dietary self-monitoring in behavioral weight-loss interventions: Current practices and future recommendations. Public Health Nutrition, 24(17), 5885–5913. https://doi.org/10.1017/S1368980021002381 Prioritizing High-Quality Protein Holt, S. H. A., Brand Miller, J. C., Petocz, P., & Farmakalidis, E. (1995). A satiety index of common foods. European Journal of Clinical Nutrition, 49(9), 675–690. Ortinau, L. C., Culp, J. M., & Hoertel, H. A. (2014). Effects of high-protein vs. high-fat snacks on appetite control, satiety, and eating initiation in healthy women. Nutrition Journal, 13, 97. https://doi.org/10.1186/1475-2891-13-97 Dhillon, J., Craig, B. A., Leidy, H. J., Amankwaah, A. F., Jacobs, A., Jones, B. L., & Jones, J. B. (2016). The effects of increased protein intake on fullness: A meta-analysis and its limitations. Journal of the Academy of Nutrition and Dietetics, 116(6), 968–983. https://doi.org/10.1016/j.jand.2016.01.003 Zhu, R., et al. (2021). Effect of a high-protein, low-glycemic index diet on hunger and weight maintenance: Results from the PREVIEW study. Frontiers in Nutrition, 8, 649928. https://doi.org/10.3389/fnut.2021.649928 Strength Training vs. Cardio Saeidifard, F., Medina-Inojosa, J. R., West, C. P., & Lopez-Jimenez, F. (2019). The role of resistance training in the prevention and management of chronic disease. European Journal of Preventive Cardiology, 26(5), 505–515. https://doi.org/10.1177/2047487318822333 Momma, H., et al. (2022). Muscle-strengthening activities and risk of all-cause and cause-specific mortality: A systematic review and meta-analysis of cohort studies. British Journal of Sports Medicine, 56(10), 755–763. https://doi.org/10.1136/bjsports-2021-105061 Cutting Ultra-Processed Foods Monteiro, C. A., Cannon, G., Levy, R. B., Moubarac, J. C., Louzada, M. L., Rauber, F., ... & Jaime, P. C. (2019). Ultra-processed foods: What they are and how to identify them. Public Health Nutrition, 22(5), 936–941. https://doi.org/10.1017/S1368980018003762 Srour, B., et al. (2019). Ultra-processed food intake and risk of cardiovascular disease: Prospective cohort study (NutriNet-Santé). BMJ, 365, l1451. https://doi.org/10.1136/bmj.l1451 Mindful Hunger / Fasting Bruce, L. J., & Ricciardelli, L. A. (2016). A systematic review of the psychosocial correlates of intuitive eating among adult women. Appetite, 96, 454–472. https://doi.org/10.1016/j.appet.2015.10.012 Longo, V. D., & Panda, S. (2016). Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan. Cell Metabolism, 23(6), 1048–1059. https://doi.org/10.1016/j.cmet.2016.06.001

Episode 124!Joining us in the studio today is Dr. John Osborne. Dr. Osborne is a Harvard-trained, world-renowned cardiologist with a Ph.D. in cardiovascular physiology.  He is a preventive heart health pioneer with over 30 years at the forefront of cutting edge heart disease prevention as a life-saver, disruptor and visionary on a mission to eradicate preventable heart disease by 2040. Dr. Osborne is currently Chief Medical Officer of ClearCardio LLC, a company leading the AI revolution in Preventive Cardiology by merging AI-driven diagnostics with science-backed, personalized medicine.Tune in to hear Dr. Osborne share how his team is changing the narrative to one where we all believe “Heart Attacks Don't Have to Happen”.  Enjoy!  ===========================================================================Follow Dr. Osborne here: Website: https://clearcardio.com/Thanks for listening! Eric Sardina Executive Life Coaching As a business and life coach, I help individuals work towards authentic lives of meaning and purpose. I also work with organizations to optimize their teams and individual contributors. Interested in working with me or learning more? Connect with me below: Website: https://www.ericsardina.com - book a free, 15-minute strategy session. https://calendly.com/ericsardina/8-session-authentically-you-discovery-call-website-linkFollow me on: Instagram: @theericsardina Facebook: Eric SardinaLinkedIn: https://www.linkedin.com/in/ericsardina/ YouTube: https://www.youtube.com/@EricSardina Affiliate: LMNT hydration drink mix: get a free sample pack with your first order by using this link: http://elementallabs.refr.cc/ericsardina

In this profound episode of Parallax, Dr Ankur Kalra welcomes Dr Pam Taub, Professor of Medicine and Director of Preventive Cardiology at UC San Diego, for an enlightening conversation about integrating spirituality, purpose, and scientific curiosity in cardiovascular practice. Dr Taub shares her unique philosophical foundation, shaped by exposure to diverse religions in South India. This experience fostered her belief that all faiths fundamentally center on being a good person and serving others. She explores how this spiritual perspective transforms medicine from a profession into a sacred calling, where patient interactions become profound privileges that fuel her desire to make meaningful impact beyond individual achievements. The episode highlights Dr Taub's groundbreaking work with POTS (Postural Orthostatic Tachycardia Syndrome), demonstrating how scientific curiosity serves as a spiritual path. Her research journey—from recognizing misdiagnosed conditions to conducting the first clinical trial for ivabradine in POTS—exemplifies how deeper questioning and evidence-based inquiry can transform patient lives on a broader scale. The episode also explores Dr Taub's research on time-restricted eating, connecting modern scientific evidence to fasting practices across many faiths. Questions and comments can be sent to "podcast@radcliffe-group.com" and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.

In our May episode, we marked Hypertension Awareness Month with Dr. Robert Ostfeld, a cardiologist at Montefiore Medical Center. Dr. Ostfeld shared how his patients naturally lowered their blood pressure by adopting a plant-based diet and offered tips for eating more plant-based foods. In this month's Key Note, he explains how getting proper sleep can reduce stress hormones that contribute to high blood pressure. The Takeaway We want to hear from you! Please complete our survey: org/member-feedback. Drop us a line at our social media channels: Facebook// Instagram // YouTube. Get started on your health journey by making an appointment with your primary care physician to know your numbers. Get to know your numbers at 1199SEIUBenefits.org/healthyhearts. Find healthy recipes and meal-prep tips at 1199SEIUBenefits.org/food-as-medicine. Visit the Healthy Living Resource Center for wellness tips, information and resources; 1199SEIUBenefits.org/healthyliving. Get inspired by fellow members through our Members' Voices series: 1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to join webinars on building healthy meals, managing stress and more: 1199SEIUBenefits.org/videos. Visit our YouTube channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists. Sample our wellness classes to exercise body and mind: 1199SEIUBenefits.org/wellnessevents. Robert Ostfeld, MD, MSc, FACC, is the Director of Preventive Cardiology at Montefiore Health System and a Professor of Medicine at the Albert Einstein College of Medicine. Dr. Ostfeld treats patients with adult cardiovascular disease, including coronary artery disease, hypertension, hyperlipidemia and erectile dysfunction with a focus on prevention and treatment through lifestyle change. He works closely with his patients to help them adopt a plant-based diet. Dr. Ostfeld received his Bachelor of Arts in the Biologic Basis of Behavior from the University of Pennsylvania, graduating Summa Cum Laude and Phi Beta Kappa and his Doctor of Medicine from Yale University School of Medicine. He then did his medical internship and residency at the Massachusetts General Hospital and his Cardiology Fellowship and Research Fellowship in Preventive Medicine at Brigham and Women's Hospital, both teaching hospitals of Harvard Medical School. During his Cardiology Fellowship, he earned a Master's of Science in Epidemiology from the Harvard School of Public Health. Dr. Ostfeld's research focus is on cardiovascular disease prevention and reversal through lifestyle modification. Ongoing topics he investigates include the impact of plant-based nutrition on erectile function, coronary artery disease, angina and heart failure. His work has been published in peer-reviewed journals, books, articles, and clinical statements and has been presented nationally. Dr. Ostfeld is board certified in Cardiovascular Disease and Echocardiography, and he is a member of numerous professional societies, including the Physician's Committee for Responsible Medicine and the American College of Cardiology.

In this conversation, Dr. Jennie Berkovich and Dr. Alan Rozanski explore the intricate relationship between stress, optimism, and cardiac health. They discuss the impact of chronic stress on cardiovascular disease, the importance of resilience, and how positive mindsets can promote longevity. The dialogue emphasizes the need for a holistic approach to health that includes behavioral management, mindfulness, and exercise. Dr. Rozanski shares insights on how to effectively communicate these concepts to patients, highlighting the significance of time management in maintaining health. The conversation concludes with a look towards the future of cardiology and patient education.Dr. Alan Rozanski is Professor of Medicine at the Icahn School of Medicine at Mount Sinai, and Chief Academic Officer, Executive Director of Cardiac Education and Fellowship Training Programs, and Director of Nuclear Cardiology for the Department of Cardiology at Mount Sinai St. Lukes.A graduate of Yale University and the Tufts University School of Medicine, Dr. Rozanski completed his Internal Medicine and Cardiology Fellowship training at Mount Sinai Hospital and a fellowship in Nuclear Medicine at Cedars-Sinai Medical Center in Los Angeles.While at Cedars-Sinai Medical Center, Dr. Rozanski founded a large multi-disciplinary program in Preventive and Rehabilitative Cardiology and initiated research which helped lead to the creation of a new field of Behavioral Cardiology. This led to a prestigious Sabbatical Fellowship from the MacArthur Foundation to study the determinants of health-promoting and health-damaging behaviors alongside many leading behavioral clinicians across the nation.In 1990, Dr. Rozanski joined the cardiology staff of St. Lukes/Roosevelt Hospital (now Mount Sinai St. Lukes and Mount Sinai West Hospitals) where he eventually served as Chief of Cardiology before assuming his current positions.Dr. Rozanski is noted for his unique clinical and academic focus and novel research that uniquely integrates the fields of Preventive Cardiology with Health Psychology and Behavioral Medicine.In addition, Dr. Rozanski is a leading expert in applying Cardiac Imaging for optimal Risk Assessment and Clinical Decision Making among patients who are candidates for cardiac testing due to risk factors or symptoms which are suggesting of heart disease.Dr. Rozanski is the co-author of over 270 peer-reviewed medical articles, book chapters and medical editorials, many of which are considered seminal contributions to the fields of Cardiology and/or Health Psychology._________________________________________________Sponsor the JOWMA Podcast! Email digitalcontent@jowma.orgBecome a JOWMA Member! www.jowma.orgFollow us on Instagram! www.instagram.com/JOWMA_orgFollow us on Twitter!www.twitter.com/JOWMA_medFollow us on Facebook! https://www.facebook.com/JOWMAorgStay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e

In this episode of the Smarter Not Harder Podcast, Dr. Abid Husain joins Dr. Scott Sherr for a masterclass on cardiovascular health — from cholesterol myths to mitochondrial truth. They explore what truly drives inflammation, plaque formation, and cardiovascular risk, while dismantling the outdated “cholesterol = heart disease” narrative. Whether you're a clinician or simply someone trying to make smarter choices for your heart, this episode offers insight into testing, interventions, and personalized strategies that go beyond basic lipid panels. Join us as we delve into: + Why LDL alone doesn't tell the full story of cardiovascular risk + How mitochondria, hormones, and inflammation intersect with lipid metabolism + The real role of CCTA scans, plaque imaging, and particle size analysis + Advanced medications and peptides that support vascular and metabolic health This episode is for you if: - You've been told to fear cholesterol but want the full picture - You're a practitioner looking to personalize cardiovascular treatment plans - You've heard of statins and PCSK9s but don't know when or why to use them - You're curious about GLP-1s, NO precursors, and other precision tools for heart health You can also find this episode on… YouTube: https://youtu.be/npYvJS2cpGc Find more from Dr. Abid Husain: Boulder Longevity: https://boulderlongevity.com LinkedIn: https://www.linkedin.com/in/abid-husain-md-facc-abaarm-00874419/ Find more from Smarter Not Harder: Website: https://troscriptions.com/blogs/podcast | https://homehope.org Instagram: @troscriptions | @homehopeorg Get 10% Off your purchase of the Metabolomics Module by using PODCAST10 at https://www.homehope.org Get 10% Off your Troscriptions purchase by using POD10 at https://www.troscriptions.com Get daily content from the hosts of Smarter Not Harder by following @troscriptions on Instagram.

Participating in religious activities appears to benefit cardiovascular health among Black Americans. It's something we explored in an episode on this podcast a few years back. Health systems, professional societies and researchers are increasingly recognizing that “faith-based organizations are trusted institutions within underserved communities and that people not only seek spiritual refuge and salvation in these places of worship, but they are also wonderful, trusted vessels to  distribute reliable health information,” says Dr. LaPrincess Brewer, a faculty member in the division of  Preventive Cardiology, department of Cardiovascular Medicine at Mayo Clinic. “Participating in religious activities from church services to private prayer, as well as holding deep spiritual beliefs are  linked to better cardiovascular health among Black Americans," according to researchers of a 2022 study published in the Journal of the American Heart Association. The researchers go on to suggest that recognition by health professionals and researchers of the centrality and influence of religiosity and spirituality in the lives of African American adults may serve as a means to address cardiovascular health disparities. In an episode that was first published in 2023, Movement Is Life's Dr. Mary O'Connor spoke with Dr. Brewer, whose primary research focus is reducing cardiovascular disease health disparities in racial and ethnic minority populations  and in underserved communities, and Clarence Jones, a community engagement specialist and former director of community engagement at a federally qualified health center in Minneapolis who has extensive experience in  collaborating with community and faith-based partners in promoting community wellness and access to health services.  Never miss an episode – be sure to subscribe to The Health Disparities podcast from Movement Is Life on Apple Podcasts, YouTube, or wherever you get your podcasts.  

Save 20% on all Nuzest Products WORLDWIDE with the code MIKKIPEDIA at www.nuzest.co.nz, www.nuzest.com.au or www.nuzest.comThis week on the podcast, Mikki speaks to Dr. Matt Budoff – a world-renowned cardiologist and researcher who has spent decades at the forefront of cardiovascular imaging and prevention. Known for his pioneering work in coronary artery calcium (CAC) scoring and computed tomography angiography (CCTA), Dr. Budoff has helped transform how we detect and assess heart disease risk.In this conversation, we explore what first sparked his interest in cardiovascular imaging and how his views on lipids, plaque, and heart disease risk have evolved over time. We dig into his recent research on lifestyle interventions—particularly low-carbohydrate and ketogenic diets—and how they affect LDL cholesterol, atherosclerosis, and overall coronary health.We also discuss the implications of his KETO study, which found no direct correlation between elevated LDL-C and plaque burden in lean, metabolically healthy individuals following a ketogenic diet.Dr. Matthew J. Budoff is a distinguished cardiologist and professor of medicine at the David Geffen School of Medicine at UCLA. He holds the Endowed Chair of Preventive Cardiology at Harbor-UCLA Medical Center and serves as the Program Director and Director of Cardiac CT in the Division of Cardiology Renowned for his pioneering work in non-invasive cardiovascular imaging, Dr. Budoff has significantly advanced the use of coronary artery calcium (CAC) scoring and computed tomography angiography (CCTA) to detect and monitor coronary artery disease. His research focuses on early detection methods for cardiac disease, aiming to identify high-risk patients and implement preventive strategies Dr. Budoff has authored or co-authored over 50 books and book chapters and more than 2,000 articles and abstracts. His contributions have been recognised with numerous awards, including the Gold Medal Award from the Society of Cardiovascular Computed Tomography and designation as a Master of the Society Matt Budoff https://profiles.ucla.edu/matthew.budoffLMHR https://www.jacc.org/doi/10.1016/j.jacadv.2024.101109  Curranz Supplement: Use code MIKKIPEDIA to get 20% off your first order - go to www.curranz.co.nz  or www.curranz.co.uk to order yours Contact Mikki:https://mikkiwilliden.com/https://www.facebook.com/mikkiwillidennutritionhttps://www.instagram.com/mikkiwilliden/https://linktr.ee/mikkiwilliden

In today's episode of The Root Cause Medicine Podcast, Dr. Kate Kresge sits down with Dr. Eve Henry to explore the often-misunderstood world of cholesterol, lipids, and heart disease risk. You'll hear them discuss: 1. Why cholesterol matters for longevity and heart health 2. Advanced lipid testing beyond standard panels 3. How to interpret ApoB, LP(a), and triglyceride levels 4. Understanding medications, supplements, and lifestyle approaches for heart health Dr. Eve Henry is board certified in Internal and Integrative Medicine. With extensive experience in personalized medicine and longevity science, she is dedicated to providing innovative care that optimizes healthspan and lifespan. She was previously Medical Director at Early Medical and is now founder of her own clinic, Eve Henry MD. She also serves as Medical Advisor to multiple start ups and enjoys her work educating leadership teams and consumers on ways to enhance their own health.